Amneal Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AMRX New York 2834 https://www.amneal.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q4 2022 Earnings Call Transcript - Mar 6th, 2023 2:48 pm
Q4 2022 Amneal Pharmaceuticals Inc Earnings Call - Mar 3rd, 2023 7:04 am
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates - Mar 2nd, 2023 12:25 pm
Amneal Announces U.S. FDA Filing Acceptance of Abbreviated New Drug Application for Naloxone Hydrochloride Nasal Spray, USP, 4mg - Mar 2nd, 2023 11:01 am
Amneal Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 2nd, 2023 11:00 am
Amneal to Report Fourth Quarter and Full Year 2022 Results on March 2, 2023 - Jan 31st, 2023 1:00 pm
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years - Jan 25th, 2023 9:06 pm
Amneal Announces Strategic European Partnership with Orion Corporation - Jan 4th, 2023 2:00 pm
Shareholders in Amneal Pharmaceuticals (NYSE:AMRX) have lost 54%, as stock drops 13% this past week - Dec 20th, 2022 2:03 pm
Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval - Dec 20th, 2022 1:00 pm
Amneal to Participate at Upcoming Investor Conferences - Nov 23rd, 2022 1:00 pm
Amneal Launches Second Biosimilar with RELEUKO® (filgrastim-ayow) in the United States - Nov 22nd, 2022 9:05 pm
FDA Accepts Amneal's (AMRX) Parkinson's Candidate NDA For Review - Nov 14th, 2022 7:05 pm
Amneal Announces U.S. FDA Filing Acceptance of New Drug Application for IPX203 for the Treatment of Parkinson’s Disease - Nov 11th, 2022 1:00 pm
Amneal Pharmaceuticals Third Quarter 2022 Earnings: Misses Expectations - Nov 9th, 2022 11:05 am
Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Lag Estimates - Nov 4th, 2022 11:25 am
Amneal Reports Third Quarter 2022 Financial Results - Nov 4th, 2022 10:00 am
Select Medical (SEM) Q3 Earnings Miss Estimates - Nov 4th, 2022 12:15 am
Amneal Receives FDA Approval for Leuprolide Acetate Injection - Nov 2nd, 2022 12:00 pm
Amneal Expands Leadership Team with Appointment of Senior Leaders in Quality and Regulatory - Oct 31st, 2022 8:05 pm